greeksoup/ stocks
Stocks / United States / MDT · Electromedical & Electrotherapeutic Apparatus · NYSE

Medtronic plc (MDT)

Compare with another name

Medtronic plc (MDT) reported revenue of $9.8 billion for Q1 FY2027, the quarter ended 31 July 2026, up 13.7% on the same quarter a year earlier. Net income was $1.5 billion, up 41.3% on the year, and diluted earnings per share $1.14. The figures are the company's own, from the 10-Q it filed with the SEC on 3 September 2026.

Revenue$9.8 billionup 13.7%
Net income$1.5 billionup 41.3%
Diluted EPS$1.14
QuarterQ1 FY2027ended 31 July 2026

Ratios

From the filings

ROE10.4%
ROCE8.9%
Operating margin18.1%
Net margin13.9%
FCF margin16.3%
Interest cover9.36
Debt to equity0.51
Cash conversion1.54
Share count, 1 year-0.1%
Sales CAGR, 3 years5.2%
Profit CAGR, 3 years8.5%
EPS, TTM$4.06

At the close of 21 September 2026

Price$91.75
Market cap$117.4 billion
Stock P/E22.60
Price to book2.34
EV / EBITDA14.54
Dividend yield3.1%
Market cap / sales3.13
52-week high$105.35
52-week low$73.75
Price, 1 year-3.5%
Price CAGR, 3 years4.6%
Price CAGR, 5 years-6.6%

Every figure is arithmetic on the filed lines (hover a name for the formula); the priced ones use the latest daily close, CBOE delayed quotes, daily history, by CBOE, for splits. Debt to equity here stands on the one borrowings figure Medtronic plc files, which has finance leases inside it; operating leases are a separate line. Nothing here is a valuation or a view.

Price, 17 September 2021 to 21 September 2026

Daily closes from CBOE delayed quotes, daily history, by CBOE, for splits; the last is 21 September 2026. P/E is the close over the trailing four quarters' EPS as filed at each filing date, on the current share count; the dashed line is the median over the range shown. Sales and margin are quarterly revenue and the operating margin from the tables above. EV/EBITDA, price to book and market cap to sales use the latest filed balance sheet and share count at each date. Drawn in your browser; the range and overlay you pick are remembered here only.

The public record on MDT

Filings24 in twelve months: 11 current reports (8-K), about 4 results of operations; 2 other events; 2 officer or director change; 2 regulation fd disclosure; 1 charter or bylaw amendment, or fiscal year change
Planned insider sales5 Form 144 notices in twelve months, $8.9 million; latest 16 September 2026
Options tapeput/call 0.57 by open interest on 23 September 2026; the straddle prices a 2.0% move to 25 September 2026
Holders12 of the followed funds hold it; largest Geode Capital Management; 3 Schedule 13D or 13G filings in twelve months
Insider trading16 sales and 0 purchases on Form 4 in twelve months
Congress5 House trades disclosed in six months
Short interest12.1 million shares short, 1.67 days to cover at 31 August 2026
Documentsthe 10-K, the 10-Qs, the proxy and 4 earnings press releases, each linked

Quarterly results, the last 12 quarters

Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026 *Q1 FY2027
Revenue7,9848,0898,5897,9158,4038,2928,9278,5788,9619,0179,8089,756
Cost of revenue2,7612,7823,0452,7612,9462,7793,1463,0013,0613,2613,3983,416
Gross profit5,2235,3075,5445,1545,4575,5135,7815,5775,9005,7566,4106,340
Gross margin65%66%65%65%65%66%65%65%66%64%65%65%
R&D698695674676697675684726754722671771
SG&A2,6862,6732,7642,6552,7572,7172,7202,8062,9652,9563,0573,198
Operating income1,3401,4831,0531,2781,5951,6461,4361,4451,6861,4641,8721,764
Operating margin17%18%12%16%19%20%16%17%19%16%19%18%
Interest expense180188203167209179174176181181177186
Pre-tax income1,3131,4728561,2681,5591,5401,2611,3021,5971,4041,8331,769
Tax rate31%9%23%17%18%15%16%20%13%18%31%16%
Net income9091,3226541,0421,2701,2941,0561,0401,3741,1431,2441,470
Net margin11%16%8%13%15%16%12%12%15%13%13%15%
Diluted EPS$0.68$0.99$0.50$0.80$0.99$1.01$0.81$0.81$1.07$0.89$0.96$1.14
Operating cash flow6612,4742,7779869582,5722,5281,0889252,7442,5731,793
Capital expenditure461346426520404476459504468444488503
Free cash flow2002,1282,3514665542,0962,0695844572,3002,0851,290
Buybacks2261321,6282,492288181274123372105435267
Dividends paid918917913898897897897910910911908921
Shares outstanding1,330m1,330m1,311m1,282m1,283m1,283m1,282m1,282m1,282m1,283m1,280m1,280m
Filing10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q

* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Profit and loss, 12 fiscal years and the trailing twelve months

FY2015FY2016 FY2017 FY2018 FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026TTM
Revenue20,26128,83329,71029,95330,55728,91330,11731,68631,22732,36433,53736,36437,542
Cost of revenue6,3099,1429,2919,0559,1559,42410,48310,14510,71911,21611,63212,72113,136
Gross profit13,95219,69120,41920,89821,40219,48919,63421,54120,50821,14821,90523,64324,406
Gross margin68.9%68.3%68.7%69.8%70.0%67.4%65.2%68.0%65.7%65.3%65.3%65.0%65.0%
Research and development1,6402,2242,1932,2532,3302,3312,4932,7462,6962,7352,7322,8732,918
Selling, general and administrative6,9049,46910,01810,23810,41810,10910,14810,29210,41510,73610,84911,78412,176
Operating income3,7665,3615,3836,6516,2684,7914,4845,7525,4855,1445,9556,4676,786
Operating margin18.6%18.6%18.1%22.2%20.5%16.6%14.9%18.2%17.6%15.9%17.8%17.8%18.1%
Interest expense6661,3861,0941,1461,4441,092925553636719729715725
Pre-tax income3,4864,3364,6025,6755,1974,0553,8955,5175,3644,8375,6286,1366,603
Income tax8117985782,580547-7512654561,5801,1339361,2991,333
Effective tax rate23.3%18.4%12.6%45.5%10.5%-18.5%6.8%8.3%29.5%23.4%16.6%21.2%20.2%
Net income2,6753,5384,0283,1044,6314,7893,6065,0393,7583,6764,6624,8015,231
Net margin13.2%12.3%13.6%10.4%15.2%16.6%12.0%15.9%12.0%11.4%13.9%13.2%13.9%
Diluted EPS$2.41$2.48$2.89$2.27$3.41$3.54$2.66$3.73$2.82$2.76$3.61$3.73$4.06
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

Income statement lines from each year's 10-K, the year linked to its filing; TTM is the sum of the last four quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are. † The year as the company last restated it in a later filing; rest on a figure for the one first filed. EPS is as filed.

Cash flow and capital returned

FY2015FY2016 FY2017 FY2018 FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026TTM
Operating cash flow4,9025,2186,8804,6847,0077,2346,2407,3466,0396,7877,0447,3308,035
Capital expenditure5711,0461,2541,0681,1341,2131,3551,3681,4591,5871,8591,9041,903
Free cash flow4,3314,1725,6263,6165,8736,0214,8855,9784,5805,2005,1855,4266,132
Free cash flow margin21.4%14.5%18.9%12.1%19.2%20.8%16.2%18.9%14.7%16.1%15.5%14.9%16.3%
Depreciation and amortisation1,3062,8202,9172,6442,6592,6632,7022,7072,6972,6472,8612,9582,939
Share-based compensation439375348344290297344359355393429457496
Buybacks1,9202,8303,5442,1712,8771,3266522,5446452,1383,2351,0351,179
Dividends paid1,3372,1392,3762,4942,6932,8943,1203,3833,6163,6663,5893,6393,650
Dividend per share$1.22$1.52$1.72$1.84$2.00$2.16$2.32$2.52$2.72$2.76$2.80$2.84n/a
Diluted shares, weighted1,109m1,426m1,391m1,368m1,358m1,351m1,354m1,351m1,333m1,330m1,290m1,288m1,285m
Shares outstanding at period end1,422m1,399m1,369m1,354m1,341m1,341m1,345m1,331m1,331m1,311m1,282m1,280m1,280m
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

Buybacks and dividends are the cash paid in the year, from the cash flow statement; the dividend per share is as declared. Diluted shares are the weighted average for the year; a falling count is the buybacks net of issuance. TTM sums the last four quarters; the share counts are the latest quarter's.

Balance sheet at year end

FY2015FY2016 FY2017 FY2018 FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026TTM
Total assets106,68599,78299,81691,39389,69490,68993,08390,98190,94889,98191,68093,02893,306
Cash and equivalents4,8432,8764,9673,6694,3934,1403,5933,7141,5431,2842,2181,9491,691
Receivables5,1125,5625,5915,9876,2224,6455,4625,5515,9986,1286,5156,6436,357
Inventory3,4633,4733,3383,5793,7534,2294,3134,6165,2935,2175,4765,9516,215
Goodwill40,53041,50038,51539,54339,95939,84141,96140,50241,42540,98641,73742,58743,187
Long-term debt33,17129,94425,87423,69224,55222,140n/an/an/an/an/an/an/a
Long-term debt including finance leases33,75230,10925,92123,69924,48622,02126,37820,37224,34423,93225,64226,17325,617
Borrowings, as the company tags them35,59030,93733,36825,75025,39024,91626,58824,27524,55325,18928,69128,131n/a
Operating lease liabilitiesn/an/an/an/an/a774829703869840918989n/a
Finance lease liabilitiesn/an/an/an/an/a45.062.056.057.055.052.054.052.0
Shareholders' equity53,23052,06350,29450,72050,09150,73751,42852,55151,48350,21448,02449,46350,232
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

At the fiscal year end; the TTM column is the latest quarter end. A line the company does not tag under the usual name is left out.

Compounded growth

10 years5 years3 yearsTTM
Sales growth, compounded2.3%3.8%5.2%9.8%
Profit growth, compounded3.1%5.9%8.5%12.3%
Return on equity, average8.3%8.7%8.9%9.7%

Compounded growth is the latest fiscal year over the year that many years earlier, annualised; the TTM column is the last four quarters over the four before. Return on equity is net income over shareholders' equity at each year end, averaged over the window (the TTM column is the latest year alone); equity is the parent's shareholders' equity as tagged in the 10-K. Arithmetic on filed numbers, nothing forecast.

Filings

FilingPeriodFiledWhere
10-Q31 July 20263 September 2026EDGAR
10-K24 April 202618 June 2026EDGAR
10-Q23 January 202624 February 2026EDGAR
10-Q24 October 202525 November 2025EDGAR
10-Q25 July 202526 August 2025EDGAR
10-K25 April 202520 June 2025EDGAR
10-Q24 January 202525 February 2025EDGAR
10-Q25 October 202426 November 2024EDGAR
10-Q26 July 202427 August 2024EDGAR
10-K26 April 202420 June 2024EDGAR

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install